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Ischemia-modiﬁed albumin(IMA)isasensitivebiomarker ofcardiacischemia. Intrauterinegrowthrestriction(IUGR)mayimply
fetal hypoxia, resulting in blood ﬂow centralization in favour of vital organs (brain, heart, adrenals—“brain sparing eﬀect”). Based
on the latter, we hypothesized that cord blood IMA levels should not diﬀer between IUGR and appropriate-for-gestational-age
(AGA) full-term pregnancies. IMA was measured in blood samples from doubly-clamped umbilical cords of 110 AGA and 57
asymmetric IUGR pregnancies. No signiﬁcant diﬀerences in IMA levels were documented between AGA and IUGR groups. IMA
levels were elevated in cases of elective cesarean section (P = .035), and oﬀspring of multigravidas (P = .021). In conclusion, “brain
sparing eﬀect” is possibly responsible for the lack of diﬀerences in cord blood IMA levels at term, between IUGR and AGA groups.
Furthermore, higher oxidative stress could account for the elevated IMA levels in cases of elective cesarean section, and oﬀspring
of multigravidas.
Copyright © 2008 Nicoletta Iacovidou et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Ischemia-modiﬁed albumin (IMA) is a relatively new
biomarker in the identiﬁcation of myocardial ischemia in
advance or in the absence of myocardial necrosis [1]. Since
IMA can be detected before troponin (a well-known marker
of necrosis) and has a high sensitivity (82%) compared to
traditional diagnostic tools (ECG-45%, troponin-20%), it is
valuable for the diagnosis of myocardial ischemia in patients
presenting with chest pain at the emergency department [1–
3]. It is well known that IMA rises within minutes from the
onset of the ischemic event and remains elevated for several
hours after cessation of ischemia [2, 3].
The pathophysiological events of ischemia, including
hypoxia,acidosis,andfreeradicalgeneration,resultinacon-
formational changeofthe N-terminus ofalbumin, leading to
a reduction in its binding with the transition metals copper,
nickel, and cobalt [4, 5]. The resulting molecule, IMA and its
reduced binding of cobalt, has been exploited to produce a
rapid automated test, the albumin cobalt binding assay [6].
Intrauterine growth restriction (IUGR) caused by chronic
malnutrition and hypoxia, (consequent to deﬁcient placental
transport of nutrients and oxygen—asymmetrical pattern
of IUGR)—is characterized by blood ﬂow redistribution to
vital organs (brain, myocardium, and adrenal glands), while
other organs are deprived from suﬃcient blood ﬂow [7–9].
This phenomenon called “the brain sparing eﬀect” is usually
accompanied by oligohydramnios [10, 11].
Taking into account “the brain sparing eﬀect,” this
study was based on the hypothesis that cord blood IMA
levels should not diﬀer between IUGR and appropriate for
gestational age (AGA) full-term pregnancies. Therefore, we
aimed to investigate cord blood IMA levels in IUGR and
AGA pregnancies at birth and correlate determined levels
with gestational age, gender, and mode of delivery.
2. SUBJECTS AND METHODS
The Ethics Committee of our teaching hospital approved
the study protocol. All included mothers provided signed
informed consent before recruitment. In the time period
from January 2006 to January 2007, one hundred and sixty2 Mediators of Inﬂammation
Table 1: Demographic data of appropriate for gestational age (AGA) and intrauterine growth restricted (IUGR) pregnancies.
AGA Mean ± SD (Median) IUGR Mean ± SD (Median) P
Birth-weight (g) 3195 ±298.5 (3200) 2595 ±264.5 (2630) <0.001
Customized Centiles 40.1 ±23 (35) 5.7 ±5.2( 5 ) <0.001
Gestational age (weeks) 39.0 ±1.0 (39.1) 38.4 ±1.4 (38.3) NS
Gender — — NS
Male 66 (60) 27 (47.4) —
Female 44 (40) 30 (52.6) —
Mode of delivery — — 0.022
Vaginal 82 (74.5) 32 (56.1) —
Elective Caesarean section 28 (25.5) 25 (43.9) —
Parity — — NS
First 79 (71.8) 37 (64.9) —
Other 31 (28.2) 20 (35.1) —
NS: nonsigniﬁcant.
seven parturients giving consecutively birth either to AGA
(n = 110) or IUGR (n = 57, birth weight below the 3rd
customizedcentile)full-termsingletoninfantswereincluded
in the study. Deliveries were performed either vaginally or
by elective caesarean section. The gestation related optimal
weight (GROW) computer-generated program [12, 13]w a s
used to calculate the customized centile for each pregnancy,
taking into consideration signiﬁcant determinants of birth
weight, such as maternal height and booking weight, ethnic
group, parity, gestational age, and gender [12].
Causes of IUGR were identiﬁed in each one of our 57
IUGR cases. Thus, 13 mothers presented with pre-eclampsia,
20withpregnancy-inducedhypertension,3withseveretype-
I diabetes mellitus, while 21 were heavy smokers during the
wholedurationofpregnancy.Amnioticﬂuidwasdiminished
in all IUGR cases. For the evaluation of the amniotic ﬂuid,
the largest ﬂuid column on the vertical plane was assessed
and was deﬁned as diminished, if < 2cm. Furthermore,
placental weight was reduced [14] ranging from 230 to 420g.
In contrast, in the AGA group, mothers were healthy
and were either nonsmokers or had abstained from smoking
during pregnancy. Moreover, placentas were normal in
appearance and weight.
All neonates had no symptoms of intrauterine infection
or stigmata of genetic syndromes. One- and ﬁve-minute
Apgar scores were ≥8 and umbilical cord pH values were
≥7.25inallIUGRcasesandAGAcontrols.Thedemographic
data of participating infants and mothers are shown in
Table 1.
Blood was collected at birth, from the doubly-clamped
umbilical cord (UC), reﬂecting the fetal state. Pyrogen-free
tubes were used and samples were immediately centrifuged
after clotting. The supernatant serum was stored at −80
◦C
until assay.
IMA was measured with the albumin cobalt binding
(ACB) test (inverness medical professional diagnostics, Bed-
ford, UK). A cobalt solution is ﬁrst added to serum, followed
by addition of dithiothreitol (DTT). DTT reacts with the
cobalt to form a colour that is measured by absorbance read
spectrophotometrically. In serum of normal patients, cobalt
bindstotheN-terminusofalbumin,whichleaveslittlecobalt
to react with DTT, producing a lighter colour. Conversely, in
serum of ischaemic patients, cobalt does not bind to the N-
terminus of IMA, which leaves more free cobalt to react with
DTT, forming a darker colour. The ACB test is conﬁgured to
run on Roche Cobas Integra 800 instrument. The minimum
detectable concentrations, intra- and inter-assay coeﬃcients
of variation were 28U/ml, 1.7% and 5.7%, respectively.
3. STATISTICAL ANALYSIS
Data regarding IMAwere normallydistributed (Kolmogorov
Smirnovtest).Linearregressionanalysiswasusedtoexamine
the eﬀect of gender, mode of delivery, parity, birth-weight,
andgestationalageonIMAlevels.Student’st-testwasusedto
detect diﬀerencesincontinuous variables(IMA,birthweight,
gestational age) between IUGR and AGA groups. Mann
Whitney U test was used to detect diﬀerences in customized
centiles between groups, since data regarding customized
centiles were not normally distributed. Pearson’s chi square
test was used to detect diﬀerences concerning gender,
mode of delivery and parity between groups. Spearman’s
or Pearson’s correlation coeﬃcient were used to detect any
positive or negative correlations. P<. 05 was considered
statistically signiﬁcant. The power calculation of the study
was 85%.
4. RESULTS
Doppler studies were performed in the IUGR group every
10–15 days, starting from the 32nd gestational week. During
eachDopplervelocimetryevaluationstudy,threeconsecutive
measurements of the pulsatility index (PI) of the studied ves-
sel were done and the mean value was recorded. Concerning
uterine and umbilical arteries [15, 16], mean PI values were
progressively found to be in the upper physiological limits
for the corresponding gestational age in 38 cases (ranging
between the 90th and the 95th percentile), while in theNicoletta Iacovidou et al. 3
remaining 19 cases PI values showed increased impedance
to ﬂow, being above the 95th percentile for gestational age.
Regarding middle cerebral arteries [17], Doppler studies
showed resistance to be in the lower physiological limits
for gestational age, indicating the initiation of blood ﬂow
redistribution process. Determined mean [95% conﬁdence
intervals (CI)] values of cord blood IMA levels were in the
AGA group 112.44 (109.95–114.92) and in the IUGR group
115.54 (111.97–119.12). No signiﬁcant diﬀerences in cord
b l o o dI M Al e v e l sw e r ef o u n db e t w e e nI U G Rc a s e sa n dA G A
controls. In both groups, cord blood IMA levels were signiﬁ-
cantly elevated in cases of caesarean section (by 4.676IU/mL
onaverage)comparedtocasesofvaginal delivery (b = 4.676,
CI 95%: 0.328–9.025, P = .035). Additionally, cord blood
IMA levels were signiﬁcantly increased (by 5.012 IU/mL on
average)incasesofmultigravidascomparedtoprimigravidas
(b = 5.072, CI 95%: 0.768–9.256, P = .021). Finally, cord
blood IMA levels did not depend on gestational age or
gender.
5. DISCUSSION
It has been recently reported that IMA is a highly sensitive
biomarker, reﬂecting the myocardial ischemic condition
prior to progression to myocardial necrosis [18–20]. In
this respect, IMA has been reported to increase after
percutaneous coronary interventions and in acute coronary
syndromes [1, 21]. In this setting, elevated IMA levels may
result from increased oxidative stress, caused by ischemia
reperfusion injury or other mechanisms linked to primary
reduction of coronary blood ﬂow or muscle damage [1, 21–
23].
Although there is a growing body of evidence regarding
IMA in the area of monitoring acute coronary syndromes in
adults [1, 18–23], data concerning the perinatal period are
sparse [24, 25]. In this respect, higher cord blood IMA values
were documented in complicated deliveries, indicating fetal
distressand/orhypoxia[24].Furthermore,elevatedmaternal
serum IMA levels have been recently demonstrated in
early normal pregnancy, supporting the hypothesis that
normaltrophoblastdevelopmentisassociatedwithahypoxic
intrauterine environment [25].
In line with our hypothesis, the results of the present
study indicate a lack of signiﬁcant diﬀerences in cord blood
IMA levels between nondistressed IUGR cases and AGA
controls,suggestingnoevidenceofmyocardialdamageinthe
former, possibly due to sparing of vital organs (e.g., brain,
heart)[7–9].Similarly, previous studies ofoursreported that
circulating levels of neurotrophins, which are important for
pre- and postnatal brain development, as well as of cardiac
troponin-I, which is a highly speciﬁc indicator of myocardial
damage, did not diﬀer between asymmetric nondistressed
IUGR and AGA groups [26, 27].
On the other hand, contrary to our expectations, cord
blood IMA levels were signiﬁcantly elevated in cases of
elective caesarean section compared to cases of vaginal
delivery. In the literature, no evidence exists whether the
fetus is subject to oxidative stress during labour [28]. Several
studieshaveshownthatumbilicalarterialbloodofnewborns
delivered vaginally or after emergent caesarean section
contains higher levels of oxidation products than the blood
of newborns delivered by elective caesarean section [29–32].
However, other reports suggest that oxidative stress in the
fetal circulation does not depend on the mode of delivery
[28]. In fact, a recent study even found that the “reservoir”
of antioxidants in the fetal red blood cell compartment is
higher in infants delivered vaginally than in those delivered
by elective caesarean section [33]. It should be noted that
all neonates included in our study were born healthy, as
evaluated by Apgar scores and pH values.
M o r e o v e r ,i no u rc o h o r t ,c o r db l o o dI M Al e v e l sw e r e
found to depend on parity, being signiﬁcantly elevated
in oﬀspring of multigravidas. Relatively, epidemiological
studies have demonstrated a consistent relationship between
the number of pregnancies and the subsequent development
of cardiovascular disease, due to an increase in oxidative
damage during late pregnancy [34, 35]. The association,
f o u n db e t w e e nc o r db l o o dI M Al e v e l sa tt e r ma n dp a r i t yi n
the present study, may have important implications in the
developmentofatherosclerosisandlong-termcardiovascular
health of women of high parity [34, 35].
Inconclusion,cordbloodIMAlevelsattermdonotdiﬀer
between IUGR cases and AGA controls, possibly due to the
sparing of vital organs, like the heart. Furthermore, higher
oxidative stress may account for the elevated cord blood
IMA levels in cases of elective caesarean section, as well as
in the oﬀspring of multigravidas. Oxidative stress indicated
by elevated IMA levels in women of high parity may have
important implications in their long-term cardiovascular
health and warrants further investigation.
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